(IN BRIEF) In early 2024, Europe's medical and research communities announced major breakthroughs in cancer care, highlighting new treatments like…
(IN BRIEF) AstraZeneca has entered into a collaboration and investment agreement with biotech firm Cellectis to fast-track the development of…
(IN BRIEF) Merck, a prominent science and technology company, has entered into a strategic partnership with Jiangsu Hengrui Pharmaceuticals. This…
(IN BRIEF) Servier, a global pharmaceutical group, has partnered with Owkin, a biotech company specializing in AI-driven drug discovery and…
(IN BRIEF) Merck, a leading science and technology company, is set to present 28 abstracts at the 2023 European Society…
(IN BRIEF) Merck, a prominent science and technology company, has announced strategic drug discovery collaborations with AI technology firms BenevolentAI…
(IN BRIEF) AstraZeneca will showcase new data from its industry-leading Oncology pipeline and portfolio at the American Association for Cancer…
(PRESS RELEASE) SANOFI, 29-Mar-2022 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced…
Tony Wood to assume full accountability for GSK R&D in August 2022 Hal Barron to transition in August 2022 from…
Topline results from the randomized EMPATHY Part A study in acute COVID-19 ambulatory patients comparing single intravenous doses of ensovibep,…
EQT Infrastructure has agreed to acquire Icon Group from a consortium including Goldman Sachs Asset Management, QIC and Pagoda. Goldman Sachs…
(PRESS RELEASE) BERLIN, 26-Jul-2021 — /EuropaWire/ — Bayer, a global enterprise with core competencies in the life science fields of…
Financing deal worth €15.0 million signed to support clinical development programme for masitinib Masitinib developed as a credible candidate for treating…
(PRESS RELEASE) CAMBRIDGE, 20-Nov-2020 — /EuropaWire/ — AstraZeneca (LON: AZN), a global, science-led biopharmaceutical company, has announced the US Food…
(PRESS RELEASE) THE HAGUE, 19-Jun-2020 — /EuropaWire/ — The Dutch Research Council (NWO) has announced that six researchers will receive…
(PRESS RELEASE) STOCKHOLM, SWEDEN / SANTA BARBARA, CALIF., USA, 15-Jun-2020 — /EuropaWire/ — Palette Life Sciences, a fully integrated global…
ACE-CL-001 trial showed an overall response rate of 97% with a sustained safety profile for previously untreated patients after more…
Tecentriq in combination with Avastin is the first and only cancer immunotherapy regimen approved for the treatment of unresectable or…
(PRESS RELEASE) CAMBRIDGE, 22-May-2020 — /EuropaWire/ — Enhertu, jointly developed by British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca and the…
The new immunotherapy will be tested in humans as soon as possible (PRESS RELEASE) ZURICH, 8-May-2020 — /EuropaWire/ — University…
San Francisco, CA, USA, 05-Nov-2018 — /EuropaWire/ — McKesson Corporation (NYSE:MCK) today announced that John H. Hammergren, chairman and chief…
DUBLIN, 30-Aug-2018 — /EuropaWire/ — Trinity is launching a new, free, online course: “From Diagnosis to Survivorship: An introduction to…
SOLAR-1 evaluated BYL719 plus fulvestrant vs. fulvestrant alone in HR+/HER2- advanced breast cancer patients with PIK3CA mutations who progressed on…
First phase of Singapore’s Advanced Medicine Imaging Center provides accurate and timely diagnosis of cancer, plus an education center for…
Kymriah demonstrated an overall response rate of 50%, with median duration of response not yet reached at the time of…
STOCKHOLM, 16-Jun-2017 — /EuropaWire/ — For nearly two decades researchers have sought a way to target an estrogen receptor in…
Agreement aims to enable precision diagnostics for pancreatic cancer by developing new methods* to resolve single-cell level differences within and…
Outlines actions underway to accelerate launch of Entresto®, including further expansion of US primary care field force, and reinforce strong…
Continued improvement in financial performance Cash and short-term investments of CHF 262.8 million Guidance on isavuconazole phase 3 topline data…
16-7-2013 — /europawire.eu/ — AstraZeneca today announced that it has entered into an agreement with the University of Cambridge and Cancer…
20-6-2013 — /europawire.eu/ — AstraZeneca and Bristol-Myers Squibb announced today top-line results of the Phase IV SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular…